GRDN Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 35.34
- PEG ratio
- —
- P/B
- 12.44
- P/S (TTM)
- 1.89
- EV/EBITDA
- 26.59
Profitability & growth
- ROE (TTM)
- 26.9%
- Operating margin
- 6.2%
- Revenue growth YoY
- 2.2%
- Dividend yield
- —
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Guardian Pharmacy Services, Inc.
Company profileGuardian Pharmacy Services, Inc. is a prominent provider of specialized pharmacy solutions dedicated to the long-term care sector, catering to assisted living and skilled nursing facilities. The company is renowned for its personalized medication management, stringent quality and compliance standards, and exceptional customer service. Leveraging advanced technology and extensive pharmaceutical expertise, Guardian enhances patient outcomes while optimizing operational efficiency for healthcare partners. With a significant operational footprint across various states, the company is…
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 300 GALLERIA PARKWAY SE, ATLANTA, GA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
